New antibody drug stops aggressive prostate cancer from spreading
Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism could open the door to a safer new treatment for advanced cancer.
Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism could open the door to a safer new treatment for advanced cancer. This story matters for Health & Wellness readers tracking gym. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. GymNews curates and briefs the health & wellness stories that matter. Our editorial policy →